Tumor targeting of the IL-15 superagonist RLI by an anti-GD2 antibody strongly enhances its antitumor potency

Title
Tumor targeting of the IL-15 superagonist RLI by an anti-GD2 antibody strongly enhances its antitumor potency
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF CANCER
Volume 133, Issue 3, Pages 757-765
Publisher
Wiley
Online
2013-01-26
DOI
10.1002/ijc.28059

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started